Regeneron's share of profits — Revenue
Regeneron Pharmaceuticals Regeneron's share of profits — Revenue decreased by 2.4% to $1.45B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.5%, from $1.02B to $1.45B. Over 2 years (FY 2022 to FY 2025), Regeneron's share of profits — Revenue shows an upward trend with a 58.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates higher profitability from collaborative products or improved performance of partner-led commercialization efforts, while a decrease may signal lower product demand or unfavorable changes in profit-sharing terms.
Detailed definition
This metric represents the company's recognized portion of net profits derived from collaborative arrangements and joint...
Peer comparison
Comparable to 'collaboration revenue' or 'equity in earnings of unconsolidated affiliates' reported by other large-cap biopharmaceutical companies with extensive joint-venture portfolios.
regn_segment_regeneron_s_share_of_profits_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $520.50M | $520.50M | $520.50M | $520.50M | $751.10M | $863.00M | $804.00M | $988.30M | $1.09B | $1.04B | $1.02B | $1.28B | $1.46B | $1.49B | $1.45B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +44.3% | +14.9% | -6.8% | +22.9% | +10.1% | -4.2% | -2.4% | +25.9% | +13.5% | +2.1% | -2.4% |
| YoY Change | — | — | — | — | +44.3% | +65.8% | — | +31.6% | +26.1% | — | +26.6% | +29.7% | +33.7% | +42.5% | +42.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's regeneron's share of profits — revenue?
- Regeneron Pharmaceuticals (REGN) reported regeneron's share of profits — revenue of $1.45B in Q1 2026.
- How has Regeneron Pharmaceuticals's regeneron's share of profits — revenue changed year-over-year?
- Regeneron Pharmaceuticals's regeneron's share of profits — revenue increased by 42.5% year-over-year, from $1.02B to $1.45B.
- What is the long-term trend for Regeneron Pharmaceuticals's regeneron's share of profits — revenue?
- Over 2 years (2022 to 2025), Regeneron Pharmaceuticals's regeneron's share of profits — revenue has grown at a 58.7% compound annual growth rate (CAGR), from $2.08B to $5.24B.
- What does regeneron's share of profits — revenue mean?
- The company's portion of net profits earned from products sold through collaborative partnerships.